Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oncothyreon Inc (NASDAQ:ONTY)

3.54
Delayed Data
As of Jul 29
 +0.03 / +0.85%
Today’s Change
1.41
Today|||52-Week Range
4.69
+86.32%
Year-to-Date
No recent news for Oncothyreon Inc.

Today’s Trading

Previous close3.51
Today’s open3.51
Day’s range-- - --
Volume702,962
Average volume (3 months)4,434,472
Market cap$359.1M
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-3.23%
Earnings growth (this year)+47.66%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...-0.10-1.51%
AMRNAmarin Corporation P...+0.03+1.40%
NVIVInVivo Therapeutics ...-0.22-1.46%
PRTOProteon Therapeutics...-0.69-3.97%
Data as of 07/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$50.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert L. Kirkman
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts